IRADIMED CORP - Common Stock (IRMD)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
4,498,571
Share change
+27,127
Total reported value
$96,357,082
Price per share
$21.38
Number of holders
60
Value change
+$270,011
Number of buys
22
Number of sells
35

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q3 2020

As of 30 Sep 2020, IRADIMED CORP - Common Stock (IRMD) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,498,571 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Nine Ten Capital Management LLC, BlackRock Inc., Russell Investments Group, Ltd., VANGUARD GROUP INC, Ranger Investment Management, L.P., RICE HALL JAMES & ASSOCIATES, LLC, RK Capital Management, LLC, Soleus Capital Management, L.P., and Mondrian Investment Partners LTD. This page lists 60 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.